We recently published a list of 10 Stocks Fall Behind Amid Market Optimism. In this article, we are going to take a look at ...

Tonix is a fully integrated biopharmaceutical company focused on transforming therapies for pain management and vaccines for public health challenges. Tonix’s development portfolio is focused on ...

Tuesday, TNXP closed at $17.45, down 2.38%, and is currently trading after hours at $17.50, up 0.29%, on the Nasdaq Capital Market. The views and opinions expressed herein are the views and ...

Another company going after the pain market - albeit in a different area - with a non-opiate pain remedy for fibromyalgia is Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP). Fibromyalgia is a ...

Stock analysts at Zacks Small Cap issued their Q1 2025 EPS estimates for shares of Tonix Pharmaceuticals in a report released on Thursday, April 3rd. Zacks Small Cap analyst D. Bautz anticipates that ...

Currently, TNXP is trading at $18.00 up by 0.76 percent on the Nasdaq. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of ...

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today ...

(RTTNews) - Tonix Pharmaceuticals (TNXP) and Makana Therapeutics announced ... of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan ...

Whether TNXP and LXEO, or indeed other biotech stocks exhibiting similar volatility, represent definitive "biotech bargains" remains a question that only time can answer. The potential for ...

In this article, we are going to take a look at where Tonix Pharmaceuticals Corp. (NASDAQ:TNXP) stands against other stocks that fall behind amid market optimism. Wall Street’s main indices ...